High-molecular-weight β-glucan decreases serum cholesterol differentially based on the CYP7A1 rs3808607 polymorphism in mildly hypercholesterolemic adults

Journal of Nutrition

Volumn 146, Issue 4, 2016, Pages 720-727

  Wang, Yanan ^a,b,e   Harding, Scott V ^a,c   Eck, Peter ^b   Thandapilly, Sijo J ^a,b,e   Gamel, Tamer H ^d   Abdel Aal, El Sayed M ^d   Crow, Gary H ^b   Tosh, Susan M ^d   Jones, Peter J H ^b,e   Ames, Nancy P ^a,b,e  

^a MORDEN RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUELPH RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^e Richardson Centre for Functional Foods and Nutraceuticals   (Canada)

Author keywords

Cholesterol; CYP7A1; Molecular weight; Polymorphism; glucan

Indexed keywords

BETA GLUCAN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; HIGH MOLECULAR WEIGHT BETA GLUCAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; CYP7A1 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; BARLEY; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MALE; MEAL; MOLECULAR WEIGHT; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BODY MASS; CHEMISTRY; GENETICS; GENOTYPING TECHNIQUE; HORDEUM; METABOLISM; MIDDLE AGED;

ADULT; AGED; ALLELES; BETA-GLUCANS; BODY MASS INDEX; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; FEMALE; GENOTYPING TECHNIQUES; HORDEUM; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MOLECULAR WEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84963830378     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.223206     Document Type: Article

References (41)

1. Health claims: soluble fiber from certain foods and risk of coronary heart disease (CHD), 21 CFR sect 101.81 (2006).
2. Health Canada. Summary of Health Canada's assessment of a health claim about barley products and blood cholesterol lowering. In: Bureau of Nutritional Sciences FD, Health Products and Food Branch, ed. Ottawa, ON: Health Canada, 2012.
3. EFSA. Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. In: Panel on Dietetic Products NaAN, ed. Parma, Italy, 2010:1885.
4. Food Standards Australia New Zealand. Standard 1.2.7: Nutrition, health and related claims. Food Standards Gazette [Internet]. 2013 [cited 2014 Jan 20]. Available from: www.foodstandards.gov.au/code/changes/gazette/documents/gazette_138.pdf.
5. Keogh GF, Cooper GJ, Mulvey TB, McArdle BH, Coles GD, Monro JA, Poppitt SD. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 2003;78:711-8.
6. Törrönen R, Kansanen L, Uusitupa M, Hanninen O, Myllymäki O, Härkönen H, Mälkki Y. Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolaemia. Eur J Clin Nutr 1992;46:621-7.
7. Behall KM, Scholfield DJ, Hallfrisch J. Lipids significantly reduced by diets containing barley in moderately hypercholesterolemic men. J Am Coll Nutr 2004;23:55-62.
8. Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007;6:6.
9. Wood P. Relationship between solution properties of cereal betaglucans and physiological effects-a review. Trends Food Sci Technol 2002;13:313-20.
10. Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V, Lamarche B, Thomson BA, Duss R, Wood PJ. Physicochemical properties of oat beta-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr 2010;92:723-32.
11. Smith KN, Queenan KM, Thomas W, Fulcher RG, Slavin JL. Physiological effects of concentrated barley beta-glucan in mildly hypercholesterolemic adults. J Am Coll Nutr 2008;27:434-40.
12. Frank J, Sundberg B, Kamal-Eldin A, Vessby B, Aman P. Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans. J Nutr 2004;134:1384-8.
13. Ordovas JM. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr 2006;83:443S-6S.
14. Jacobs DR, Jr., Anderson JT, Hannan P, Keys A, Blackburn H. Variability in individual serum cholesterol response to change in diet. Arteriosclerosis 1983;3:349-56.
15. Abdullah MM, Jones PJ, Eck PK. Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era. Nutr Rev 2015;73:523-43.
16. Jenkins DJ, Hegele RA, Jenkins AL, Connelly PW, Hallak K, Bracci P, Kashtan H, Corey P, Pintilia M, Stern H, et al. The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber. Metabolism 1993;42:585-93.
17. Shen J, Arnett DK, Parnell LD, Lai CQ, Straka RJ, Hopkins PN, An P, Feitosa MF, Ordovas JM. The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate. J Cardiovasc Pharmacol 2012;59:254-9.
18. Kajinami K, Brousseau ME, Ordovas JM, Schaefer EJ. A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin. Atherosclerosis 2005;180:407-15.
19. Hubacek JA, Pitha J, Skodova Z, Poledne R, Lanska V, Waterworth DM, Humphries SE, Talmud PJ. Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clin Biochem 2003;36:263-7.
20. Kovár J, Suchánek P, Hubácek JA, Poledne R. The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiol Res 2004;53:565-8.
21. De Castro-Oŕos I, Pampin S, Cofán M, Mozas P, Pintó X, Salas-Salvadó J, Rodríguez-Rey JC, Ros E, Civeira F, Pocoví M. Promoter variant-204A > C of the cholesterol 7alpha-hydroxylase gene: association with response to plant sterols in humans and increased transcriptional activity in transfected HepG2 cells. Clin Nutr 2011;30:239-46 10.1016/j.clnu.2010.07.020.
22. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137-74.
23. Fuchs M. Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: past progress and future challenges. Am J Physiol Gastrointest Liver Physiol 2003;284:G551-7.
24. Lu Y, Feskens EJ, Boer JM, Muller M. The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population. Atherosclerosis 2010;210:14-27.
25. Gamel TH, Tosh SM, Badali K. Changes of b-glucan physicochemical characteristics in frozen and freeze dried oat bran bread and porridge. J Cereal Sci 2013;58:104-9.
26. Beer MU, Wood PJ, Weisz J, Fillion N. Effect of cooking and storage on the amount and molecular weight of (1-3)(1-4)-b-D-glucan extracted from oat products by an in vitro digestion system. Cereal Chem J 1997;74:705-9.
27. Tosh SM, Brummer Y, Miller SS, Regand A, Defelice C, Duss R, Wolever TMS, Wood PJ. Processing affects the physicochemical properties of betaglucan in oat bran cereal. J Agric Food Chem 2010;58:7723-30.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
29. Recommendations for the treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis of the American Heart Association. Arteriosclerosis 1984;4:443A-68A.
30. Ginsberg HN, Barr SL, Gilbert A, Karmally W, Deckelbaum R, Kaplan K, Ramakrishnan R, Holleran S, Dell RB. Reduction of plasma cholesterol levels in normal men on an American Heart Association Step 1 diet or a Step 1 diet with added monounsaturated fat. N Engl J Med 1990;322:574-9 10.1056/NEJM199003013220902.
31. Andersson M, Ellegard L, Andersson H. Oat bran stimulates bile acid synthesis within 8 h as measured by 7 alpha-hydroxy-4-cholesten-3-one. Am J Clin Nutr 2002;76:1111-6.
32. Ellegård L, Andersson H. Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. Eur J Clin Nutr 2007;61:938-45.
33. Zhang JX, Hallmans G, Andersson H, Bosaeus I, Aman P, Tidehag P, Stenling R, Lundin E, Dahlgren S. Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr 1992;56:99-105.
34. Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JA. Mechanism of serum-cholesterol reduction by oat bran. Hepatology 1994;20:1450-7.
35. Lia A, Andersson H, Mekki N, Juhel C, Senft M, Lairon D. Postprandial lipemia in relation to sterol and fat excretion in ileostomy subjects given oat-bran and wheat test meals. Am J Clin Nutr 1997;66:357-65.
36. Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2014;100:1413-21.
37. Mahley RW, Rall SC, Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507-37.
38. Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, et al. Ensembl 2013. Nucleic Acids Res 2013;41:D48-55.
39. Jiao Y, Lu Y, Li XY. Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacol Sin 2015;36:44-50.
40. Angelin B, Hershon KS, Brunzell JD. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci USA 1987;84:5434-8.
41. Bateson MC, Maclean D, Evans JR, Bouchier IA. Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. Br J Clin Pharmacol 1978;5:249-54